RANDOMISED PHASE III STUDY OF BEVACIZUMAB plus CHEMOTHERAPY BEYOND PROGRESSION IN BEVACIZUMAB-TREATED PATIENTS WITH METASTATIC COLORECTAL CANCER: TML STUDY KRAS SUBGROUP FINDINGS

被引：0

作者：

Van Cutsem, Eric ^{[1
]}

Maria Vieitez, Jose ^{[2
]}

Bouche, Olivier ^{[3
]}

Osterlund, Pia ^{[4
]}

Bennouna, Jaafar ^{[5
]}

Andre, Thierry ^{[6
]}

Sastre, Javier ^{[7
]}

Alonso-Orduna, Vicente ^{[8
]}

Kubicka, Stefan ^{[9
]}

Greil, Richard ^{[10
]}

von Moos, Roger ^{[11
]}

Reyes-Rivera, Irmarie ^{[12
]}

Scherer, Stefan ^{[12
]}

Bendahmane, Belguendouz ^{[13
]}

Arnold, Dirk ^{[14
]}

机构：

[1] Univ Hosp Gasthuisberg, B-3000 Louvain, Flemish Brabant, Belgium

[2] Cent Univ Hosp Asturias HUCA, Oviedo, Spain

[3] Ctr Hosp Univ Robert Debre, Reims, France

[4] Univ Helsinki, Cent Hosp, Helsinki, Finland

[5] Inst Cancerol Ouest, Nantes, St Herblain, France

[6] Hop St Antoine, F-75571 Paris, France

[7] Serv Oncol Med HC, Madrid, Spain

[8] Hosp Univ Miguel Servet, Zaragoza, Spain

[9] Canc Ctr Reutlingen, Reutlingen, Germany

[10] III Med Univ Klin Salzburg, Salzburg, Austria

[11] Kantonsspital Graubuenden, Chur, Switzerland

[12] Genentech Inc, San Francisco, CA 94080 USA

[13] F Hoffmann La Roche & Co Ltd, CH-4002 Basel, Switzerland

[14] Univ Canc Ctr Hamburg UCCH, Hubertus Wald Tumor Ctr, Hamburg, Germany

来源：

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：15 / 15

页数：1